Chemical Compound
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-, (5Z)-; 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-, (5Z)- (9CI); 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-, [1R-[1a(Z),2ss(1E,3S*),3a,5a]]-; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic acid; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid; 17-Phenyl-18,19,20-trinor-PGF2a; 17-Phenyl-18,19,20-trinorprostaglandin F2a; Bimatoprost acid; PhXA 70; U 35687
CAS Registry Number
38344-08-0
Primary record
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-, (5Z)-; 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-, (5Z)- (9CI); 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-, [1R-[1a(Z),2ss(1E,3S*),3a,5a]]-; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic acid; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid; 17-Phenyl-18,19,20-trinor-PGF2a; 17-Phenyl-18,19,20-trinorprostaglandin F2a; Bimatoprost acid; PhXA 70; U 35687
- 库存
- 1,305 克
- 纯度
- 98.9 %
- CAS
- 38344-08-0
化合物标识与属性
- CAS
- 38344-08-0
- PubChem CID
- 5283081
- SMILES
- C1[C@@H]([C@@H]([C@H]([C@@H]1O)/C=C/[C@H](CCC2=CC=CC=C2)O)C/C=C\CCCC(=O)O)O
- Canonical SMILES
- O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O
名称与同义词
- Bimatoprost Acid
- 38344-08-0
- 17-phenyl-trinor-PGF2alpha
- Bimatoprost, free acid
- bimatoprost (free acid form)
- AC1NR1HD
- Bimatoprost Acid Impurity
- RefChem:568349
- BIMATOPROST IMPURITY C
- PHXA 70
- PHXA-70
- 17-Phenyl trinor prostaglandin F2alpha
- D08QWQ
- UNII-2683MK55HG
- 2683MK55HG
- CHEMBL3914661
- YFHHIZGZVLHBQZ-KDACTHKWSA-N
- 17-phenyl-omega-trinor-PGF2alpha
- DTXSID001316541
- GTPL1959
- orb1306499
- SCHEMBL2472056
- C23H32O5
- 17-phenyl-trinor-Prostaglandin F2alpha
- CHEBI:73773
- Cid 6441592
- DTXCID801746382
- 17-PHENYLTRINORPROSTAGLANDINF2ALPHA
- 17-PHENYL-TRINOR PGF 2.ALPHA.
- 1272AH
- 17-PHENYL-TRINOR PGF 2ALPHA
- 17-Phenyltrinorprostagrandin F2alpha
- BDBM50206014
- LMFA03010081
- ZINC13589949
- AKOS040744735
- 17-Phenyl-18,19,20-trinorprostaglandin F2alpha
- ACN-041395
- C23-H32-O5
- CID5283081
- 17-Phenyl Trinor Prostaglandin F2-Alpha
- AC-30204
- BB173258
- TS-08131
- U-35687
- HY-125774
- J395.293B
- CS-0099304
- FT-0639459
- U 35687
- 17-PHENYL-18,19,20-TRINOR-PGF2.ALPHA.
- H20484
- (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)hept-5-enoic acid
- 17-PHENYL-18,19,20-TRINOR-PGF2ALPHA
- 17-PHENYL-18,19,20-TRINORPROSTAGLANDIN F2.ALPHA.
- Q27075269
- (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid
- 9S,11R,15S-trihydroxy-17-phenyl-18,19,20-trinor-5Z,13E-prostadienoic acid
- B0444-467545
- (5Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3S)-3-HYDROXY-5-PHENYL-1-PENTEN-1-YL)CYCLOPENTYL)-5-HEPTENOIC ACID
- (5Z)-7-[(1R)-3alpha,5alpha-Dihydroxy-2beta-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentan-1alpha-yl]-5-heptenoic acid
- (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid
- (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid
- (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}hept-5-enoic acid
- 5-HEPTENOIC ACID, 7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3S)-3-HYDROXY-5-PHENYL-1-PENTEN-1-YL)CYCLOPENTYL)-, (5Z)-
- 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-
- 9alpha,11alpha,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-oic acid
- (5Z)-7-((1R)-3a,5a-Dihydroxy-2b-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentan-1a-yl)-5-heptenoic acid
- (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoic acid
- (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]hept-5-enoic acid
- (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl}-5-heptenoic acid
- (5Z)-7-{(1R,2R,3S,5S)-3,5-dihydroxy-2-[(1E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}hept-5-enoic acid
- (5Z,13E,15S)-9alpha,11alpha,15-Trihydroxy-17-phenyl-18,19,20-trinorprosta-5,13-diene-1-oic acid
- (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxy-17-phenyl-18,19,20-trinorprosta-5,13-diene-1-oic acid
- (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]cyclopentyl]hept-5-enoic acid
- (Z)-7-[(1R,2R,3S,5S)-3,5- paragraph signthornoC>>u-2-[(E)-3-oC>>u-5-+/-(1/2)>>uIi-1-I(c)>>u]>>.Ii>>u] y-5-I(c)Ea
- (Z)-7-[(1R,2R,3S,5S)-3,5-dihydroxy-2-[(E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid
- 5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-5-PHENYL-1- PENTENYL)CYCLOPENTYL)-, (1R- (1.ALPHA.(Z),2.BETA.(1E,3S*),3.ALPHA.,5.ALPHA.))-
- 5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-5-PHENYL-1-PENTENYL)CYCLOPENTYL)-, (1R-(1.ALPHA.(Z),2.BETA.(1E,3S*),3.ALPHA.,5.ALPHA.))-
- 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-, (5Z)-; 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-, (5Z)- (9CI); 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-, [1R-[1a(Z),2ss(1E,3S*),3a,5a]]-; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic acid; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid; 17-Phenyl-18,19,20-trinor-PGF2a; 17-Phenyl-18,19,20-trinorprostaglandin F2a; Bimatoprost acid; PhXA 70; U 35687
- 806-621-0